Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Total Liabilities (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Total Liabilities data on record, last reported at $13.9 million in Q4 2025.

  • For Q4 2025, Total Liabilities fell 21.11% year-over-year to $13.9 million; the TTM value through Dec 2025 reached $13.9 million, down 21.11%, while the annual FY2025 figure was $13.9 million, 21.11% down from the prior year.
  • Total Liabilities reached $13.9 million in Q4 2025 per PLSE's latest filing, down from $16.1 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $81.4 million in Q3 2022 and bottomed at $12.9 million in Q1 2024.
  • Average Total Liabilities over 5 years is $27.7 million, with a median of $15.9 million recorded in 2025.
  • Peak YoY movement for Total Liabilities: surged 497.24% in 2021, then plummeted 84.08% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $14.8 million in 2021, then skyrocketed by 441.6% to $80.1 million in 2022, then crashed by 81.54% to $14.8 million in 2023, then grew by 18.95% to $17.6 million in 2024, then dropped by 21.11% to $13.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $13.9 million in Q4 2025, $16.1 million in Q3 2025, and $15.8 million in Q2 2025.